Logo image of MS

MORGAN STANLEY (MS) Stock Fundamental Analysis

USA - NYSE:MS - US6174464486 - Common Stock

155.565 USD
-0.09 (-0.05%)
Last: 10/9/2025, 3:14:06 PM
Fundamental Rating

3

Taking everything into account, MS scores 3 out of 10 in our fundamental rating. MS was compared to 238 industry peers in the Capital Markets industry. MS may be in some trouble as it scores bad on both profitability and health. MS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year MS was profitable.
MS had a negative operating cash flow in the past year.
Each year in the past 5 years MS has been profitable.
The reported operating cash flow has been mixed in the past 5 years: MS reported negative operating cash flow in multiple years.
MS Yearly Net Income VS EBIT VS OCF VS FCFMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B

1.2 Ratios

With a Return On Assets value of 1.04%, MS is not doing good in the industry: 65.97% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of 13.07%, MS is in the better half of the industry, outperforming 69.75% of the companies in the same industry.
With a Return On Invested Capital value of 1.34%, MS is not doing good in the industry: 66.81% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for MS is significantly below the industry average of 7.64%.
The 3 year average ROIC (1.17%) for MS is below the current ROIC(1.34%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.04%
ROE 13.07%
ROIC 1.34%
ROA(3y)0.89%
ROA(5y)0.97%
ROE(3y)10.46%
ROE(5y)11.1%
ROIC(3y)1.17%
ROIC(5y)1.28%
MS Yearly ROA, ROE, ROICMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

The Profit Margin of MS (12.51%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of MS has declined.
MS has a Operating Margin of 17.07%. This is in the lower half of the industry: MS underperforms 62.18% of its industry peers.
MS's Operating Margin has declined in the last couple of years.
The Gross Margin of MS (54.42%) is better than 65.97% of its industry peers.
In the last couple of years the Gross Margin of MS has declined.
Industry RankSector Rank
OM 17.07%
PM (TTM) 12.51%
GM 54.42%
OM growth 3Y-20.12%
OM growth 5Y-4.82%
PM growth 3Y-20.6%
PM growth 5Y-5.48%
GM growth 3Y-16.51%
GM growth 5Y-5.78%
MS Yearly Profit, Operating, Gross MarginsMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

0

2. Health

2.1 Basic Checks

MS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, MS has more shares outstanding
The debt/assets ratio for MS is higher compared to a year ago.
MS Yearly Shares OutstandingMS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
MS Yearly Total Debt VS Total AssetsMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B 1T

2.2 Solvency

MS has an Altman-Z score of -0.09. This is a bad value and indicates that MS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.09, MS is doing worse than 76.89% of the companies in the same industry.
A Debt/Equity ratio of 7.45 is on the high side and indicates that MS has dependencies on debt financing.
MS has a worse Debt to Equity ratio (7.45) than 88.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.45
Debt/FCF N/A
Altman-Z -0.09
ROIC/WACCN/A
WACCN/A
MS Yearly LT Debt VS Equity VS FCFMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100B 200B

2.3 Liquidity

MS has a Current Ratio of 0.29. This is a bad value and indicates that MS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.29, MS is not doing good in the industry: 81.93% of the companies in the same industry are doing better.
A Quick Ratio of 0.29 indicates that MS may have some problems paying its short term obligations.
The Quick ratio of MS (0.29) is worse than 81.51% of its industry peers.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.29
MS Yearly Current Assets VS Current LiabilitesMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 42.19% over the past year.
Measured over the past years, MS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.88% on average per year.
Looking at the last year, MS shows a quite strong growth in Revenue. The Revenue has grown by 10.36% in the last year.
Measured over the past years, MS shows a quite strong growth in Revenue. The Revenue has been growing by 14.79% on average per year.
EPS 1Y (TTM)42.19%
EPS 3Y-0.38%
EPS 5Y8.88%
EPS Q2Q%17.03%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y20.63%
Revenue growth 5Y14.79%
Sales Q2Q%11.81%

3.2 Future

Based on estimates for the next years, MS will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.26% on average per year.
Based on estimates for the next years, MS will show a small growth in Revenue. The Revenue will grow by 6.32% on average per year.
EPS Next Y15.44%
EPS Next 2Y11.58%
EPS Next 3Y11.04%
EPS Next 5Y10.26%
Revenue Next Year11.99%
Revenue Next 2Y8.44%
Revenue Next 3Y7.21%
Revenue Next 5Y6.32%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MS Yearly Revenue VS EstimatesMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B 80B 100B
MS Yearly EPS VS EstimatesMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.62, which indicates a rather expensive current valuation of MS.
The rest of the industry has a similar Price/Earnings ratio as MS.
Compared to an average S&P500 Price/Earnings ratio of 27.91, MS is valued a bit cheaper.
With a Price/Forward Earnings ratio of 15.74, MS is valued correctly.
MS's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.30. MS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.62
Fwd PE 15.74
MS Price Earnings VS Forward Price EarningsMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

MS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MS is cheaper than 72.69% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.17
MS Per share dataMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

MS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.14
PEG (5Y)1.98
EPS Next 2Y11.58%
EPS Next 3Y11.04%

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.58%, MS has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 8.50, MS has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.44, MS has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.58%

5.2 History

On average, the dividend of MS grows each year by 18.94%, which is quite nice.
MS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)18.94%
Div Incr Years0
Div Non Decr Years0
MS Yearly Dividends per shareMS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

45.08% of the earnings are spent on dividend by MS. This is a bit on the high side, but may be sustainable.
The dividend of MS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP45.08%
EPS Next 2Y11.58%
EPS Next 3Y11.04%
MS Yearly Income VS Free CF VS DividendMS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B
MS Dividend Payout.MS Dividend Payout, showing the Payout Ratio.MS Dividend Payout.PayoutRetained Earnings

More info and screens

MORGAN STANLEY

NYSE:MS (10/9/2025, 3:14:06 PM)

155.565

-0.09 (-0.05%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)07-16 2025-07-16/bmo
Earnings (Next)10-15 2025-10-15/bmo
Inst Owners62.51%
Inst Owner Change0%
Ins Owners0.2%
Ins Owner Change-0.04%
Market Cap248.33B
Analysts73.13
Price Target151.26 (-2.77%)
Short Float %1.34%
Short Ratio3.24
Dividend
Industry RankSector Rank
Dividend Yield 2.58%
Yearly Dividend3.8
Dividend Growth(5Y)18.94%
DP45.08%
Div Incr Years0
Div Non Decr Years0
Ex-Date07-31 2025-07-31 (1)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.13%
Min EPS beat(2)5.77%
Max EPS beat(2)14.48%
EPS beat(4)4
Avg EPS beat(4)15.64%
Min EPS beat(4)5.77%
Max EPS beat(4)27.07%
EPS beat(8)7
Avg EPS beat(8)10.97%
EPS beat(12)10
Avg EPS beat(12)7.76%
EPS beat(16)13
Avg EPS beat(16)7.12%
Revenue beat(2)2
Avg Revenue beat(2)2.67%
Min Revenue beat(2)1.43%
Max Revenue beat(2)3.91%
Revenue beat(4)4
Avg Revenue beat(4)3.45%
Min Revenue beat(4)1.43%
Max Revenue beat(4)4.78%
Revenue beat(8)6
Avg Revenue beat(8)1.67%
Revenue beat(12)9
Avg Revenue beat(12)12.16%
Revenue beat(16)12
Avg Revenue beat(16)9.8%
PT rev (1m)1.82%
PT rev (3m)15.57%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)3.18%
EPS NY rev (1m)0.03%
EPS NY rev (3m)2.49%
Revenue NQ rev (1m)0.29%
Revenue NQ rev (3m)3.47%
Revenue NY rev (1m)0.31%
Revenue NY rev (3m)2.57%
Valuation
Industry RankSector Rank
PE 17.62
Fwd PE 15.74
P/S 2.2
P/FCF N/A
P/OCF N/A
P/B 2.3
P/tB 2.91
EV/EBITDA 20.17
EPS(TTM)8.83
EY5.68%
EPS(NY)9.89
Fwd EY6.35%
FCF(TTM)-13.12
FCFYN/A
OCF(TTM)-11.07
OCFYN/A
SpS70.8
BVpS67.77
TBVpS53.41
PEG (NY)1.14
PEG (5Y)1.98
Profitability
Industry RankSector Rank
ROA 1.04%
ROE 13.07%
ROCE 3.03%
ROIC 1.34%
ROICexc 1.49%
ROICexgc 1.57%
OM 17.07%
PM (TTM) 12.51%
GM 54.42%
FCFM N/A
ROA(3y)0.89%
ROA(5y)0.97%
ROE(3y)10.46%
ROE(5y)11.1%
ROIC(3y)1.17%
ROIC(5y)1.28%
ROICexc(3y)1.31%
ROICexc(5y)1.45%
ROICexgc(3y)1.39%
ROICexgc(5y)1.53%
ROCE(3y)2.71%
ROCE(5y)2.95%
ROICexcg growth 3Y-7.03%
ROICexcg growth 5Y1.53%
ROICexc growth 3Y-6.98%
ROICexc growth 5Y1.26%
OM growth 3Y-20.12%
OM growth 5Y-4.82%
PM growth 3Y-20.6%
PM growth 5Y-5.48%
GM growth 3Y-16.51%
GM growth 5Y-5.78%
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 7.45
Debt/FCF N/A
Debt/EBITDA 33.05
Cap/Depr 64.3%
Cap/Sales 2.89%
Interest Coverage 0.4
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.29
Altman-Z -0.09
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)74.75%
Cap/Depr(5y)63.46%
Cap/Sales(3y)3.81%
Cap/Sales(5y)3.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.19%
EPS 3Y-0.38%
EPS 5Y8.88%
EPS Q2Q%17.03%
EPS Next Y15.44%
EPS Next 2Y11.58%
EPS Next 3Y11.04%
EPS Next 5Y10.26%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y20.63%
Revenue growth 5Y14.79%
Sales Q2Q%11.81%
Revenue Next Year11.99%
Revenue Next 2Y8.44%
Revenue Next 3Y7.21%
Revenue Next 5Y6.32%
EBIT growth 1Y35.01%
EBIT growth 3Y-3.64%
EBIT growth 5Y9.26%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.99%
OCF growth 3Y-65.77%
OCF growth 5Y-49.33%